{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:29:22Z","timestamp":1793039362794,"version":"4.5.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"publisher","award":["NSFC81370109"],"award-info":[{"award-number":["NSFC81370109"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Innovation Program of Shanghai Municipal Education Commission","award":["13SG21"],"award-info":[{"award-number":["13SG21"]}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"crossref","award":["10120151101"],"award-info":[{"award-number":["10120151101"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.rmed.2016.11.019","type":"journal-article","created":{"date-parts":[[2016,11,26]],"date-time":"2016-11-26T00:32:10Z","timestamp":1480120330000},"page":"33-42","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":109,"special_numbering":"C","title":["Beneficial effects of Omalizumab therapy in allergic bronchopulmonary aspergillosis: A synthesis review of published literature"],"prefix":"10.1016","volume":"122","author":[{"given":"Jian-Xiong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Chao","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man-Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Jun","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8039-8973","authenticated-orcid":false,"given":"Jin-Fu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2016.11.019_bib1","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jaci.2011.12.970","article-title":"Fungi and allergic lower respiratory tract diseases","volume":"129","author":"Knutsen","year":"2012","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2016.11.019_bib2","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3109\/1040841X.2012.754401","article-title":"Allergic bronchopulmonary mycosis due to fungi other than Aspergillus: a global overview","volume":"40","author":"Chowdhary","year":"2014","journal-title":"Crit. Rev. Microbiol."},{"key":"10.1016\/j.rmed.2016.11.019_bib3","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1128\/CMR.12.2.310","article-title":"Aspergillus fumigatus and aspergillosis","volume":"12","author":"Latg\u00e9","year":"1999","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.rmed.2016.11.019_bib4","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1365-2222.2011.03944.x","article-title":"The role of allergy in severe asthma","volume":"42","author":"Kennedy","year":"2012","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.rmed.2016.11.019_bib5","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/cea.12141","article-title":"Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria","volume":"43","author":"Agarwal","year":"2013","journal-title":"Clin. Exp. Allergy"},{"issue":"Suppl 3","key":"10.1016\/j.rmed.2016.11.019_bib6","doi-asserted-by":"crossref","first-page":"S225","DOI":"10.1086\/376525","article-title":"Allergic bronchopulmonary aspergillosis in cystic fibrosis\u2013state of the art: cystic Fibrosis Foundation Consensus Conference","volume":"37","author":"Stevens","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.rmed.2016.11.019_bib7","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1378\/chest.116.3.639","article-title":"Allergic bronchopulmonary aspergillosis in cystic fibrosis: reported prevalence, regional distribution, and patient characteristics. Scientific Advisory Group, Investigators, and Coordinators of the Epidemiologic Study of Cystic Fibrosis","volume":"116","author":"Geller","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2016.11.019_bib8","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3109\/13693786.2012.738312","article-title":"Global burden of allergic bronchopulmonary aspergillosis with asthma and its complication chronic pulmonary aspergillosis in adults","volume":"51","author":"Denning","year":"2013","journal-title":"Med. Mycol."},{"key":"10.1016\/j.rmed.2016.11.019_bib9","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1136\/thx.7.4.317","article-title":"Broncho-pulmonary aspergillosis; a review and a report of eight new cases","volume":"7","author":"Hinson","year":"1952","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2016.11.019_bib10","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1164\/rccm.2008-740ST","article-title":"An official American Thoracic Society statement: treatment of fungal infections in adult pulmonary and critical care patients","volume":"183","author":"Limper","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2016.11.019_bib11","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1067\/mai.2003.1388","article-title":"Anti-inflammatory effect of itraconazole in stable allergic bronchopulmonary aspergillosis: a randomized controlled trial","volume":"111","author":"Wark","year":"2003","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2016.11.019_bib12","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1183\/09031936.00139513","article-title":"Treatment options in severe fungal asthma and allergic bronchopulmonary aspergillosis","volume":"43","author":"Moss","year":"2014","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2016.11.019_bib13","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2165\/00003495-200161020-00008","volume":"61","author":"Easthope","year":"2001","journal-title":"Omalizumab. Drugs"},{"key":"10.1016\/j.rmed.2016.11.019_bib14","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/S0140-6736(08)61449-X","article-title":"New targets for drug development in asthma","volume":"372","author":"Adcock","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.rmed.2016.11.019_bib15","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1067\/mai.2001.117880","article-title":"Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma","volume":"108","author":"Busse","year":"2001","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2016.11.019_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta17520","article-title":"Omalizumab for the treatment of severe persistent allergic asthma: a systematic review and economic evaluation","volume":"17","author":"Norman","year":"2013","journal-title":"Health Technol. Assess."},{"key":"10.1016\/j.rmed.2016.11.019_bib17","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa1009705","article-title":"Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children","volume":"364","author":"Busse","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.rmed.2016.11.019_bib18","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jaci.2014.02.007","article-title":"Incidence of malignancy in patients with moderate-to-severe asthma treated with or without omalizumab","volume":"134","author":"Long","year":"2014","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2016.11.019_bib19","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJMoa1215372","article-title":"Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria","volume":"368","author":"Maurer","year":"2013","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.rmed.2016.11.019_bib20","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1136\/thx.2004.035519","article-title":"Successful treatment of allergic bronchopulmonary aspergillosis with recombinant anti-IgE antibody","volume":"62","author":"Van der Ent","year":"2007","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2016.11.019_bib21","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/ppul.20804","article-title":"Steroid-sparing effect of omalizumab for allergic bronchopulmonary aspergillosis and cystic fibrosis","volume":"43","author":"Jacquelyn","year":"2008","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.rmed.2016.11.019_bib22","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1002\/ppul.20907","article-title":"Treatment of allergic bronchopulmonary aspergillosis (ABPA) in CF with anti-IgE antibody (omalizumab)","volume":"43","author":"Kanu","year":"2008","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.rmed.2016.11.019_bib23","first-page":"477","article-title":"Successful treatment of allergic bronchopulmonary aspergillosis with omalizumab","volume":"64","author":"Alcorta","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.rmed.2016.11.019_bib24","first-page":"130","article-title":"Steroid dependency despite omalizumab treatment of ABPA in cystic fibrosis","volume":"65","author":"Brinkmann","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.rmed.2016.11.019_bib25","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/ppul.21002","article-title":"Omalizumab for treatment of ABPA exacerbations in CF patients","volume":"44","author":"Lebecque","year":"2009","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.rmed.2016.11.019_bib26","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1579-2129(09)71023-7","article-title":"Effective anti-immunoglobulin-E antibody treatment of a patient with allergic bronchopulmonary aspergillosis","volume":"45","author":"Quintas Vazquez","year":"2009","journal-title":"Arch. Bronconeumol"},{"key":"10.1016\/j.rmed.2016.11.019_bib27","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1080\/02770900902849871","article-title":"Resolution of corticosteroid-induced diabetes in allergic bronchopulmonary aspergillosis with omalizumab therapy: a novel approach","volume":"46","author":"Randhawa","year":"2009","journal-title":"J.\u00a0Asthma"},{"issue":"Suppl 1","key":"10.1016\/j.rmed.2016.11.019_bib28","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1258\/jrsm.2009.s19011","article-title":"Life-threatening allergic bronchopulomnary aspergillosis treated with methylprednisolone and anti-IgE monoclonal antibody","volume":"102","author":"Thomas","year":"2009","journal-title":"J.\u00a0R. Soc. Med."},{"key":"10.1016\/j.rmed.2016.11.019_bib29","doi-asserted-by":"crossref","first-page":"AB68","DOI":"10.1016\/j.jaci.2009.12.268","article-title":"Prolonged suppression of IgE levels associated with allergic bronchopulmonary aspergillosis treated with omalizumab","volume":"125","author":"Bhargave","year":"2010","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2016.11.019_bib30","doi-asserted-by":"crossref","first-page":"942","DOI":"10.3109\/02770903.2010.491144","article-title":"Measured immunoglobulin E in allergic bronchopulmonary aspergillosis treated with omalizumab","volume":"47","author":"Lin","year":"2010","journal-title":"J.\u00a0Asthma"},{"key":"10.1016\/j.rmed.2016.11.019_bib31","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1136\/thx.2010.153312","article-title":"Effects of omalizumab in Aspergillus-associated airway disease","volume":"66","author":"P\u00e9rez-de-Llano","year":"2011","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2016.11.019_bib32","article-title":"Following total IgE concentration in patients with ABPA on omalizumab","author":"Kelso","year":"2015","journal-title":"J.\u00a0Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.rmed.2016.11.019_bib33","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/j.1398-9995.2011.02599.x","article-title":"Allergic bronchopulmonary Aspergillosis and omalizumab","volume":"66","author":"Tillie-Leblond","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.rmed.2016.11.019_bib34","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2147\/JAA.S34579","article-title":"Allergic bronchopulmonary aspergillosis treated successfully for one year with omalizumab","volume":"5","author":"Collins","year":"2012","journal-title":"J.\u00a0asthma allergy"},{"key":"10.1016\/j.rmed.2016.11.019_bib35","first-page":"A93","article-title":"Great neck N. Delayeddiagnosisofallergicbronchopulmonary aspergillosis inanasthmatic patient on Xolair:a case report","volume":"109","author":"Hirsch","year":"2012","journal-title":"Ann. Allergy, Asthma & Immunol."},{"key":"10.1016\/j.rmed.2016.11.019_bib36","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1016\/S1569-1993(12)60519-0","article-title":"Effectiveness of omalizumab for treatment of allergic bronchopulmonary aspergillosis (ABPA) among children and adolescents with cystic fibrosis","volume":"11","author":"Hatziagorou","year":"2012","journal-title":"J.\u00a0Cyst. Fibros."},{"key":"10.1016\/j.rmed.2016.11.019_bib37","first-page":"145","article-title":"A\u00a0case of allergic bronchopulmonary aspergillosis treated with omalizumab","volume":"22","author":"I Sastre","year":"2012","journal-title":"J.\u00a0Investig. Allergol. Clin. Immunol."},{"key":"10.1016\/j.rmed.2016.11.019_bib38","first-page":"88","article-title":"Management of patients with cystic fibrosis and allergic bronchopulmonary aspergillosis using anti-immunoglobulin E therapy (omalizumab)","volume":"17","author":"ElMallah","year":"2012","journal-title":"J.\u00a0Pediatr. Pharmacol. Ther."},{"key":"10.1016\/j.rmed.2016.11.019_bib39","first-page":"49","article-title":"The use of biological agents for the treatment of fungal asthma and allergic bronchopulmonary aspergillosis","volume":"1272","author":"Moss","year":"2012","journal-title":"Adv. against Aspergillosis I"},{"key":"10.1016\/j.rmed.2016.11.019_bib40","article-title":"Anti-IgE therapy for allergic bronchopulmonary aspergillosis","volume":"28","author":"Homma","year":"2013","journal-title":"J.\u00a0Microbiol. Immunol. Infect."},{"key":"10.1016\/j.rmed.2016.11.019_bib41","first-page":"362","article-title":"Efficacy of omalizumab treatment in allergic bronchopulmonary aspergillosis","volume":"68","author":"Martorell","year":"2013","journal-title":"Allergy Eur. J. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2016.11.019_bib42","first-page":"362","article-title":"Efficacy of omalizumab treatment in allergic bronchopulmonary aspergillosis","volume":"68","author":"Martorell","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.rmed.2016.11.019_bib43","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.prrv.2012.11.004","article-title":"Omalizumab in the management of steroid dependent allergic bronchopulmonary aspergillosis (ABPA) complicating cystic fibrosis","volume":"14","author":"Wong","year":"2013","journal-title":"Paediatr. Respir. Rev."},{"key":"10.1016\/j.rmed.2016.11.019_bib44","first-page":"18","article-title":"Anti IgE antibody as treatment of allergic bronchopulmonary aspergillosis in a patient with cystic fibrosis","volume":"2014","author":"Zicari","year":"1839","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.rmed.2016.11.019_bib45","first-page":"527","article-title":"Two cases whereby a heavy persistant allergic asthma controlled by omalizumab and allergic bronchopulmoner aspergillosis co-exist","volume":"69","author":"Bulut","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.rmed.2016.11.019_bib46","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1177\/1753465814547517","article-title":"Omalizumab: a new treatment option for allergic bronchopulmonary aspergillosis in patients with cystic fibrosis","volume":"8","author":"Lehmann","year":"2014","journal-title":"Ther. Adv. Respir. Dis."},{"key":"10.1016\/j.rmed.2016.11.019_bib47","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2500\/aap.2015.36.3909","article-title":"Omalizumab in the treatment of allergic bronchopulmonary aspergillosis: one center's experience with 14 cases","volume":"36","author":"Aydin","year":"2015","journal-title":"Allergy Asthma Proc."},{"key":"10.1016\/j.rmed.2016.11.019_bib48","first-page":"143","article-title":"Steroid sparing effect of omalizumab in seropositive allergic bronchopulmonary aspergillosis","volume":"6","author":"Beam","year":"2015","journal-title":"Allergy Rhinol. Provid."},{"key":"10.1016\/j.rmed.2016.11.019_bib49","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jaip.2014.12.008","article-title":"Clinical efficacy and immunologic effects of omalizumab in allergic bronchopulmonary aspergillosis","volume":"3","author":"Voskamp","year":"2015","journal-title":"J.\u00a0Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.rmed.2016.11.019_bib50","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2288-5-13","article-title":"Estimating the mean and variance from the median, range, and the size of a sample","volume":"5","author":"Hozo","year":"2005","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.rmed.2016.11.019_bib51","first-page":"749","article-title":"Aspergillus ribotoxins react with IgE and IgG antibodies of patients with allergic bronchopulmonary aspergillosis","volume":"123","author":"Kurup","year":"1994","journal-title":"J.\u00a0Lab. Clin. Med."},{"issue":"Suppl 3","key":"10.1016\/j.rmed.2016.11.019_bib52","doi-asserted-by":"crossref","first-page":"S225","DOI":"10.1086\/376525","article-title":"Allergic bronchopulmonary aspergillosis in cystic fibrosis\u2013state of the art","volume":"37","author":"Stevens","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.rmed.2016.11.019_bib53","first-page":"Cd002204","article-title":"Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis","volume":"11","author":"Elphick","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.rmed.2016.11.019_bib54","first-page":"Cd010288","article-title":"Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis","volume":"11","author":"Jat","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.rmed.2016.11.019_bib55","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/ppul.22937","article-title":"Omalizumab therapy for allergic bronchopulmonary aspergillosis in children with with cystic fibrosis: a synthesis of published evidence","volume":"49","author":"Tanou","year":"2014","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.rmed.2016.11.019_bib56","doi-asserted-by":"crossref","first-page":"e114745","DOI":"10.1371\/journal.pone.0114745","article-title":"Estimated burden of serious fungal infections in Jamaica by literature review and modelling","volume":"9","author":"Agarwal","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.rmed.2016.11.019_bib57","first-page":"936","article-title":"Aspergillus hypersensitivity and allergic bronchopulmonary aspergillosis in in patients with bronchial asthma: systematic review and meta-analysis","volume":"13","author":"Agarwal","year":"2009","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"10.1016\/j.rmed.2016.11.019_bib58","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1378\/chest.130.2.442","article-title":"Allergic bronchopulmonary aspergillosis: lessons from 126 patients attending a chest clinic in north India","volume":"130","author":"Agarwal","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2016.11.019_bib59","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jaci.2006.10.026","article-title":"In response to dosing omalizumab in allergic asthma","volume":"119","author":"Jaffe","year":"2007","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2016.11.019_bib60","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1378\/chest.125.4.1378","article-title":"Predicting response to omalizumab, an anti-IgE antibody, in patients with","volume":"125","author":"Bousquet","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2016.11.019_bib61","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.jaci.2003.10.003","article-title":"Omalizumab treatment downregulates dendritic cell FcepsilonRI expression","volume":"112","author":"Prussin","year":"2003","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2016.11.019_bib62","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1189\/jlb.70.2.207","article-title":"IgE-regulated loss, not IgE-regulated synthesis, controls expression of FcepsilonRI in human basophils","volume":"70","author":"MacGlashan","year":"2001","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.rmed.2016.11.019_bib63","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nri2273","article-title":"IgE in allergy and asthma today","volume":"8","author":"Gould","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.rmed.2016.11.019_bib64","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1126\/science.1099472","article-title":"Defining a link with asthma in mice congenitally deficient in eosinophils","volume":"305","author":"Lee","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.rmed.2016.11.019_bib65","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.jaci.2015.09.008","article-title":"Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost","volume":"136","author":"Teach","year":"2015","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2016.11.019_bib66","first-page":"Cd003559","article-title":"Omalizumab for asthma in adults and children","volume":"1","author":"Normansell","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.rmed.2016.11.019_bib67","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1183\/09031936.02.00278102","article-title":"Omalizumab provides long-term control in patients with moderate-to-severe allergic asthma","volume":"20","author":"Buhl","year":"2002","journal-title":"Eur. Respir. J."},{"issue":"5","key":"10.1016\/j.rmed.2016.11.019_bib68","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/all.12815","article-title":"\u201cReal-life\u201d effectiveness studies of omalizumab in adult patients with severe allergic asthma: systematic review","volume":"71","author":"Abraham","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.rmed.2016.11.019_bib69","first-page":"81","article-title":"Long-term efficacy and safety of omalizumab in patients with persistent uncontrolled allergic asthma: a systematic review and meta-analysis","volume":"5","author":"Lai","year":"2015","journal-title":"Sci. Rep."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095461111630316X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095461111630316X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:35:09Z","timestamp":1760614509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095461111630316X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":69,"alternative-id":["S095461111630316X"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2016.11.019","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beneficial effects of Omalizumab therapy in allergic bronchopulmonary aspergillosis: A synthesis review of published literature","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2016.11.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}